Free Trial

MDxHealth (MDXH) Competitors

$2.79
+0.10 (+3.72%)
(As of 07/12/2024 ET)

MDXH vs. CNTG, NH, TLIS, LUCD, FONR, SERA, LH, DGX, NTRA, and EXAS

Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include Centogene (CNTG), NantHealth (NH), Talis Biomedical (TLIS), Lucid Diagnostics (LUCD), FONAR (FONR), Sera Prognostics (SERA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Natera (NTRA), and Exact Sciences (EXAS). These companies are all part of the "medical" sector.

MDxHealth vs.

MDxHealth (NASDAQ:MDXH) and Centogene (NASDAQ:CNTG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.

9.9% of Centogene shares are held by institutional investors. 1.7% of MDxHealth shares are held by insiders. Comparatively, 1.9% of Centogene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Centogene has lower revenue, but higher earnings than MDxHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MDxHealth$70.19MN/A-$43.10MN/AN/A
Centogene$52.53MN/A-$38.58MN/AN/A

Centogene received 27 more outperform votes than MDxHealth when rated by MarketBeat users. Likewise, 64.52% of users gave Centogene an outperform vote while only 52.00% of users gave MDxHealth an outperform vote.

CompanyUnderperformOutperform
MDxHealthOutperform Votes
13
52.00%
Underperform Votes
12
48.00%
CentogeneOutperform Votes
40
64.52%
Underperform Votes
22
35.48%

In the previous week, MDxHealth had 3 more articles in the media than Centogene. MarketBeat recorded 6 mentions for MDxHealth and 3 mentions for Centogene. Centogene's average media sentiment score of 1.19 beat MDxHealth's score of 0.15 indicating that Centogene is being referred to more favorably in the news media.

Company Overall Sentiment
MDxHealth Neutral
Centogene Positive

MDxHealth has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Centogene has a beta of -0.67, meaning that its stock price is 167% less volatile than the S&P 500.

MDxHealth currently has a consensus price target of $7.50, suggesting a potential upside of 168.82%. Given MDxHealth's higher possible upside, equities analysts clearly believe MDxHealth is more favorable than Centogene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MDxHealth
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Centogene
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
MDxHealthN/A N/A N/A
Centogene N/A N/A N/A

Summary

Centogene beats MDxHealth on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXH vs. The Competition

MetricMDxHealthMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.27B$5.40B$8.73B
Dividend YieldN/A2.00%2.77%4.04%
P/E RatioN/A14.83120.3416.71
Price / SalesN/A129.412,180.4083.84
Price / CashN/A337.4936.4333.15
Price / Book0.604.184.944.46
Net Income-$43.10M-$128.23M$111.51M$215.59M
7 Day Performance19.23%7.21%6.20%5.35%
1 Month Performance1.45%4.21%5.71%4.39%
1 Year Performance-92.12%-9.66%6.49%1.77%

MDxHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNTG
Centogene
1.1477 of 5 stars
1.15 / 5 stars
$0.45
+2.3%
N/A-65.2%$0.00$52.53M0.00444Short Interest ↓
Gap Up
NH
NantHealth
0 of 5 stars
0.00 / 5 stars
$0.03
flat
N/A-93.4%$231,000.00$67.68M0.00326Analyst Forecast
News Coverage
TLIS
Talis Biomedical
0.3637 of 5 stars
0.36 / 5 stars
$8.70
+0.9%
$5.00
-42.5%
+4.4%$15.83M$2.13M-0.2899Positive News
LUCD
Lucid Diagnostics
1.3014 of 5 stars
1.30 / 5 stars
$0.84
+2.4%
$4.33
+416.5%
-36.9%$43.98M$2.43M-0.6670Short Interest ↑
News Coverage
FONR
FONAR
0 of 5 stars
0.00 / 5 stars
$16.00
-0.4%
N/A-1.2%$101.28M$98.64M10.26561Analyst Upgrade
Short Interest ↑
News Coverage
SERA
Sera Prognostics
0.5342 of 5 stars
0.53 / 5 stars
$5.29
-1.7%
$2.75
-48.0%
+94.2%$172.72M$310,000.00-4.9455
LH
Laboratory Co. of America
4.9539 of 5 stars
4.95 / 5 stars
$199.35
-1.8%
$243.07
+21.9%
-2.6%$16.81B$12.16B40.1167,000Analyst Forecast
Positive News
DGX
Quest Diagnostics
4.9028 of 5 stars
4.90 / 5 stars
$138.36
-0.4%
$147.15
+6.4%
+2.4%$15.37B$9.25B18.6248,000Analyst Upgrade
News Coverage
NTRA
Natera
1.0539 of 5 stars
1.05 / 5 stars
$109.43
-0.1%
$101.19
-7.5%
+119.7%$13.44B$1.08B-35.073,293Positive News
EXAS
Exact Sciences
4.5639 of 5 stars
4.56 / 5 stars
$44.09
-2.4%
$86.80
+96.9%
-53.0%$8.14B$2.53B-33.406,600Short Interest ↑
News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:MDXH) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners